Table 2 Clinical and pathological characteristics of the study population
From: Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
| Variable | Patients (n = 80) | Control subjects (n = 82) | P value |
|---|---|---|---|
| Age (year) | 65.1 ± 10.5 | 34.8 ± 7.3 | < 0.001 |
| Gender | 0.090 | ||
| Male | 57 | 48 | |
| Female | 23 | 34 | |
| Tumor size (cm) | 4.27 ± 2.62 | ||
| > 5 | 49 | ||
| ≥ 5 | 31 | ||
| TNM stage | |||
| I | 20 | ||
| II | 18 | ||
| III | 31 | ||
| IV | 11 | ||
| Histological grade | |||
| I | 4 | ||
| II | 14 | ||
| II~III | 25 | ||
| IV | 37 | ||
| Lauren classification | |||
| Diffuse | 25 | ||
| Intestinal | 31 | ||
| Mixed | 24 | ||
| Tumor localization | |||
| Cardia | 19 | ||
| Corpus | 8 | ||
| Antrum | 43 | ||
| Whole | 10 | ||
